Mesosil is a dental materials company that has created antimicrobial systems for patients and dental practitioners that reduce the rate of cavities and implant infections, decreasing patient pain and reducing treatment complications. The application of dental fillings costs about $9b per year in the US, and these fillings have a 12% failure rate after only 5 years. With 36% of the world’s population having gone under the drill at some point in their life, most people will want to avoid repeating the experience. This is why we have developed antimicrobial releasing systems that may be combined with current dental clinical materials to combat recurrent cavities and implant infection in new, premium products.

Team Members

Cameron Stewart

Benjamin Hatton

Yoav Finer
Chief Medical Officer